TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 47 filers reported holding TYRA BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,725,576 | -19.1% | 4,409,991 | 0.0% | 53.26% | +0.1% |
| Q2 2023 | $75,102,147 | +6.0% | 4,409,991 | 0.0% | 53.19% | +4.3% |
| Q1 2023 | $70,868,555 | +111.4% | 4,409,991 | 0.0% | 50.98% | +93.7% |
| Q4 2022 | $33,515,932 | -13.5% | 4,409,991 | 0.0% | 26.32% | +68.3% |
| Q3 2022 | $38,764,000 | +22.9% | 4,409,991 | 0.0% | 15.63% | +39.2% |
| Q2 2022 | $31,531,000 | -33.2% | 4,409,991 | 0.0% | 11.23% | -42.8% |
| Q1 2022 | $47,187,000 | -24.0% | 4,409,991 | 0.0% | 19.65% | +22.9% |
| Q4 2021 | $62,049,000 | – | 4,409,991 | – | 15.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $47,187,000 | 19.65% |
| Nextech Invest Ltd. | 2,518,582 | $26,949,000 | 7.69% |
| TCG Crossover Management, LLC | 896,418 | $9,592,000 | 3.85% |
| Boxer Capital, LLC | 6,448,359 | $68,997,000 | 3.55% |
| Fairmount Funds Management LLC | 1,284,990 | $13,749,000 | 3.25% |
| RA Capital Management | 7,236,454 | $77,430,000 | 1.69% |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $14,206,000 | 1.21% |
| BVF INC/IL | 2,472,327 | $26,454,000 | 1.06% |
| Cormorant Asset Management, LP | 757,432 | $8,105,000 | 0.62% |
| Sio Capital Management, LLC | 111,033 | $1,188,000 | 0.39% |